Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition

Carcinogenesis

Volumn 35, Issue 12, 2014, Pages 2716-2722

  Nieters, Alexandra ^a   Luczynska, Anna ^a   Becker, Susen ^b   Becker, Nikolaus ^c   Vermeulen, Roel ^d,e   Overvad, Kim ^f   Aleksandrova, Krasimira ^g   Boeing, Heiner ^g   Lagiou, Pagona ^h,j   Trichopoulos, Dimitrios ^i,j   Trichopoulou, Antonia ^h,k   Krogh, Vittorio ^l   Masala, Giovanna ^m   Panico, Salvatore ⁿ   Tumino, Rosario ^o   Sacerdote, Carlotta ^p,q   Bueno de Mesquita, Bas ^d,r   M Jeurnink, Suzanne ^d,r   Weiderpass, Elisabete ^s,t,u,v   Ardanaz, Eva ^w,x   Chirlaque, Maria Dolores ^w,y   Sánchez, María José ^w,z   Sánchez, Soledad ^aa   Borgquist, Signe ^ab   Butt, Salma ^ac   Melin, Beatrice ^ad   Späth, Florentin ^ad   Rinaldi, Sabina ^ae   Brennan, Paul ^ae   S Kelly, Rachel ^i,af   Riboli, Elio ^ag   Vineis, Paolo ^q,af   Kaaks, Rudolf ^c   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f AARHUS UNIVERSITY   (Denmark)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^j BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^k HELLENIC HEALTH FOUNDATION   (Greece)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o Cancer Registry and Histopathology Unit   (Italy)

^p Center for Cancer Prevention CPO Piemonte   (Italy)

^q Human Genetics Foundation   (Italy)

^r NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^s UNIVERSITY OF TROMSØ   (Norway)

^t CANCER REGISTRY OF NORWAY   (Norway)

^u KAROLINSKA INSTITUTE   (Sweden)

^v UNIVERSITY OF HELSINKI   (Finland)

^w CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^x INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^y DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^z Andalusia School of Public Health   (Spain)

^aa Public Health Directorate   (Spain)

^ab LUND UNIVERSITY HOSPITAL   (Sweden)

^ac LUND UNIVERSITY   (Sweden)

^ad UMEÅ UNIVERSITY   (Sweden)

^ae INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^af Faculty of Medicine and MRC Health Protection Agency   (United Kingdom)

^ag IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME TO TREATMENT; B LYMPHOCYTE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; IMMUNOLOGY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; MULTICENTER STUDY; PROGNOSIS;

ADULT; AGED; B-LYMPHOCYTES; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84927733395     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu188     Document Type: Article

References (42)

1. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Grulich, A.E. et al. (2007) Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev., 16, 405-408.
3. Ekström Smedby, K. et al. (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood, 111, 4029-4038.
4. Goldin, L.R. et al. (2009) Autoimmunity and lymphomagenesis. Int. J. Cancer, 124, 1497-1502.
5. Vajdic, C.M. et al. (2009) Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res., 69, 6482-6489.
6. Kogevinas, M. et al. (2004) Occupational exposure to immunologically active agents and risk for lymphoma. Cancer Epidemiol. Biomarkers Prev., 13, 1814-1818.
7. Wild, L.G. et al. (2003) Occupational asthma caused by high-molecularweight substances. Immunol. Allergy Clin. North Am., 23, 235-250.
8. Agrawal, D.K. et al. (2010) Pathogenesis of allergic airway inflammation. Curr. Allergy Asthma Rep., 10, 39-48.
9. Holt, P.G. et al. (2009) Pathogenic mechanisms of allergic inflammation: atopic asthma as a paradigm. Adv. Immunol., 104, 51-113.
10. Jensen-Jarolim, E. et al. (2008) AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy, 63, 1255-1266.
11. Merrill, R.M. et al. (2007) The association between allergies and cancer: what is currently known? Ann. Allergy. Asthma Immunol., 99, 102-16; quiz 117.
12. Melbye, M. et al. (2007) Atopy and risk of non-Hodgkin lymphoma. J. Natl Cancer Inst., 99, 158-166.
13. Grulich, A.E. et al. (2007) Re: atopy and risk of non-Hodgkin lymphoma. J. Natl Cancer Inst., 99, 1417.
14. Lindelöf, B. et al. (2005) Allergy and cancer. Allergy, 60, 1116-1120.
15. Van Hemelrijck, M. et al. (2010) Immunoglobulin E and cancer: a metaanalysis and a large Swedish cohort study. Cancer Causes Control, 21, 1657-1667.
16. Mills, P.K. et al. (1992) Allergy and cancer: organ site-specific results from the Adventist Health Study. Am. J. Epidemiol., 136, 287-295.
17. Wang, H. et al. (2005) Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy, 60, 1098-1111.
18. McWhorter, W.P. (1988) Allergy and risk of cancer. A prospective study using NHANESI followup data. Cancer, 62, 451-455.
19. Talbot-Smith, A. et al. (2003) Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort. Am. J. Epidemiol., 157, 606-612.
20. Söderberg, K.C. et al. (2004) Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health, 4, 51.
21. Eriksson, N.E. et al. (1995) A prospective study of cancer incidence in a cohort examined for allergy. Allergy, 50, 718-722.
22. Bingham, S. et al. (2004) Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat. Rev. Cancer, 4, 206-215.
23. Jaffe, E.S. (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am. Soc. Hematol. Educ. Program, 3, 523-531.
24. Zetterström, O. et al. (1981) IgE concentrations measured by PRIST in serum of healthy adults and in patients with respiratory allergy. A diagnostic approach. Allergy, 36, 537-547.
25. Paganelli, R. et al. (1998) Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy, 53, 763-768.
26. Gould, H.J. et al. (2008) IgE in allergy and asthma today. Nat. Rev. Immunol., 8, 205-217.
27. Pate, M.B. et al. (2010) Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective. Clin. Mol. Allergy, 8, 3.
28. Iio, A. et al. (1977) The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions. J. Clin. Invest., 59, 743-755.
29. Ellison-Loschmann, L. et al. (2007) Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain. Cancer Epidemiol. Biomarkers Prev., 16, 1492-1498.
30. Biggar, R.J. et al. (2009) Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int. J. Cancer, 124, 2616-2620.
31. Hamblin, A.D. et al. (2008) The immunodeficiency of chronic lymphocytic leukaemia. Br. Med. Bull., 87, 49-62.
32. Ravandi, F. et al. (2006) Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol. Immunother., 55, 197-209.
33. Tsai, H.T. et al. (2009) Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood, 114, 4928-4932.
34. Leechawengwongs, E. et al. (2012) Lymphoma complicating primary immunodeficiency syndromes. Curr. Opin. Hematol., 19, 305-312.
35. Rezaei, N. et al. (2011) Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J. Allergy Clin. Immunol., 127, 1329-41.e2; quiz 1342.
36. Karagiannis, S.N. et al. (2003) Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur. J. Immunol., 33, 1030-1040.
37. Karagiannis, S.N. et al. (2007) IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells. J. Immunol., 179, 2832-2843.
38. Fu, S.L. et al. (2008) Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin. Exp. Immunol., 153, 401-409.
39. Nigro, E.A. et al. (2009) Antitumor IgE adjuvanticity: key role of Fc epsilon RI. J. Immunol., 183, 4530-4536.
40. Martínez-Maza, O.et al. (2010) Epidemiological evidence: IgE, allergies, and hematopoietic malignancies. In Penichet, M.L. and Jensen-Jarolim, E. (eds) Cancer and Ig: Introducing the Concept of Allergo Oncology. Humana Press, New York, NY, pp. 79-136.
41. Miyake, Y. et al. (2004) Relationship between active and passive smoking and total serum IgE levels in Japanese women: baseline data from the Osaka Maternal and Child Health Study. Int. Arch. Allergy Immunol., 135, 221-228.
42. González-Quintela, A. et al. (2003) Association of alcohol consumption with total serum immunoglobulin E levels and allergic sensitization in an adult population-based survey. Clin. Exp. Allergy, 33, 199-205.